LiveActive security incident?Get immediate response
CVE Record

CVE-2021-41835: Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algorithm

Fresenius Kabi Agilia Link + version 3.0 does not enforce transport layer encryption. Therefore, transmitted data may be sent in cleartext. Transport layer encryption is offered on Port TCP/443, but the affected service does not perform an automated redirect from the unencrypted service on Port TCP/80 to the encrypted service.

HighCVSS 7.3Not KEV-listedUpdated
Glexia's TakeAutomated analysishigh

Security readout for executives and security teams

Plain-English summary

Fresenius Kabi Agilia Link+ can send data without encryption if users or integrations reach the service over TCP/80. For executives, the concern is avoidable exposure of medical device communications in clinical networks, with potential confidentiality, integrity, and availability impact, not a confirmed active attack campaign.

Executive priority

Treat as a high-priority medical technology exposure review. Prioritize sites where Agilia Link+ is network reachable across broad internal segments or untrusted paths, because encryption is available but not enforced.

Technical view

CVE-2021-41835 is CWE-327 in Fresenius Kabi Agilia Link+ version 3.0. The service offers TLS on TCP/443 but does not force encryption or redirect TCP/80 traffic to HTTPS. CVSS 3.1 is 7.3, network exploitable, low complexity, no privileges or user interaction, with low C/I/A impact.

Likely exposure

Exposure is likely where Fresenius Kabi Agilia Link+ version 3.0, or unspecified affected Agilia Link+ versions, remain reachable over unencrypted TCP/80 on clinical or operational networks.

Exploitation context

The source bundle does not show CISA KEV listing or confirmed active exploitation. The weakness is practical when an attacker can observe or influence network traffic to the affected service, but the provided sources do not describe public exploit tooling or attack activity.

Researcher notes

Evidence is narrow: the bundle identifies plaintext transport caused by lack of HTTP-to-HTTPS enforcement. It does not provide packet details, patch versions, or exploit observations. Validate exposure defensively without publishing traffic contents or attack procedures.

Mitigation direction

  • Prefer the encrypted service on TCP/443 for all Agilia Link+ access.
  • Disable or block TCP/80 where operationally safe and vendor-approved.
  • Check Fresenius Kabi and CISA advisory guidance for supported remediation.
  • Limit network reachability to trusted clinical management networks only.
  • Review compensating controls before making clinical system changes.

Validation and detection

  • Inventory Fresenius Kabi Agilia Link+ deployments and confirm versions.
  • Verify whether TCP/80 is reachable from user, server, and network segments.
  • Confirm workflows use TCP/443 rather than unencrypted TCP/80.
  • Review network captures or logs for cleartext Agilia Link+ traffic.
  • Document any version ambiguity and request vendor confirmation.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-327: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2021-41835 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
High
CVSS
7.3 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
7.3CVSS 3.1HighCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L3.93.4Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

7.3High
CVSS 3.1 vector shape for CVE-2021-41835Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Fresenius KabiAgilia Link+unspecifiedListed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-327 · source CWE mapping

Use of a Broken or Risky Cryptographic Algorithm

Use of a Broken or Risky Cryptographic Algorithm represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.